panaxadiol
8
relevant articles (0 outcomes,
2 trials/studies)
found for this Bio-Agent
Description:
a protopanaxadiol with the side chain cyclized into a pyran which is an artifact of acidic hydrolysis; RN refers to (3 beta,12 beta,20R)-isomer
Also Known As:
panaxadiol, (3beta,12beta)-isomer; (3 beta,12 beta,20R)-20,25-epoxydammarane-3,12- diol
Bio-Agent Context: Research Results
Experts
Related Diseases
| 1. | Hepatocellular Carcinoma (Hepatoma)
|
| 2. | Burns
|
| 3. | Neoplasms (Cancer)
11/01/2006
- " Furthermore, the anti-tumor activities of panaxadiol fatty acid ester derivates showed positive correlation with subjects' concentrations, but no relationship with molecular weight of fatty acid." 11/01/2006
- " The result showed that compound I had the strongest anti-tumor activity, second was panaxadiol, II and III had the same and the weakest antitumor activity" 11/01/2006
- " For making use of Ginseng resources and finding new anti-tumor drugs, the anti-tumor activity of three kinds of new panaxadiol fatty acid ester derivates: 3beta-acetoxy panaxadiol (I), 3beta-palmitic acid aceloxy panaxadiol (II), 3beta-octadecanoic acid aceloxy panaxadiol (Ill) and panaxaiol were compared through the method of cell stain and counting" 11/01/2006
- " Primary research on anti-tumor activity of panaxadiol fatty acid esters]" 11/01/2003
- " We show that panaxadiol (PD), a ginseng saponin with a dammarane skeleton, selectively interferes with the cell cycle in human cancer cell lines"
Get all the results and reference details, order at left...
|
| 4. | Sarcoma (Soft Tissue Sarcoma)
|
| 5. | Fibrosarcoma
|
| 7 Diseases
and
8
more articles analyzed in the Research Interface, order at left...
|
Related Drugs and Biologics